This image provided by Blue Origin shows the Blue Moon lander. Jeff Bezos' Blue Origin received a $3.4 billion contract Friday, May 19, 2023, to develop a lunar lander named Blue Moon. It will be used to transport astronauts to the lunar surface as early as 2029. (Blue Origin via AP)
By Marcia Dunn
Jeff Bezos' rocket company has won a NASA contract to land astronauts on the moon, two years after it lost out to SpaceX.
Blue Origin received a $3.4 billion contract Friday to lead a team to develop a lunar lander named Blue Moon. It will be used to transport astronauts to the lunar surface as early as 2029, following a pair of crew landings by Elon Musk’s SpaceX.
NASA will get astronauts to lunar orbit using its own rockets and capsules, but wants private companies to take over from there.
NASA Administrator Bill Nelson said the agency wants different landing options as it seeks a return to the moon more than a half-century after the end of the Apollo moonshots.
Blue Origin is kicking in billions of dollars, on top of the NASA contract, to help establish a permanent presence on the moon.
“We have a lot to do before we successfully land and return astronauts," said John Couluris, a Blue Origin vice president.
Two years ago, Blue Origin sued after NASA awarded SpaceX the contract for the first lunar landing. A federal judge upheld the space agency’s decision.
NASA’s Artemis program, which follows the 1960s and 1970s Apollo moonshots. kicked off with a successful test flight late last year. Launched atop NASA's new moon rocket, an empty Orion capsule went into lunar orbit before returning home.
The next Artemis flight will come late next year when one Canadian and three U.S. astronauts fly to the moon and back, but not land. Two Americans would descend to the lunar surface aboard a SpaceX Starship on the mission after that, no earlier than late 2025.
Like SpaceX, Blue Origin plans to practice landing on the moon without a crew, before putting astronauts on board.
While the shiny, stainless steel Starship has a science fiction look, Blue Moon resembles more of a traditional capsule perched atop a tall compartment with legs. The latter will stand 52 feet (16 meters) on the moon.
Both companies' landers are meant to be reusable.
Blue Origin will use its still-in-development New Glenn rocket to launch its lunar missions from Cape Canaveral. Starship, the world's largest rocket, made its debut last month from South Texas; the test flight ended in an explosive fireball a few minutes into flight.
Blue Origin's team includes five partners: Lockheed Martin, Boeing, Draper, Astrobotic Technology and Honeybee Robotics.
Only one other bid was submitted for the contract competition, according to NASA.
___
The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content.
Energy costs continue to rise, our electrical grid is outdated, and the focus on renewable energy is more important than ever. One company says it has an answer: pods that store solar energy for long-term, 24-hour usage that can also function as mini power grids and charge electric vehicles. Azelio's TES.PODs store solar energy during the day, and hold it for use around the clock, providing a solution for charging electric vehicles, powering rural areas, and much more. Jonas Wallmander, CEO of Azelio, joins Closing Bell to discuss the company's solar energy storage technology, how it can be used to power communities and build out electric vehicle charging infrastructure, and more.
Catching you up with what you need to know on Apr 12, 2022, with Russia concentrating forces in eastern Ukraine, rising inflation, severe weather from Minnesota to the Gulf Coast, Philadelphia brings back its indoor mask mandate, PG&E pays $55 million for wildfire settlement, and more
Catching you up on what you need to know on April 11, 2022, with updates on the Russia-Ukraine War, France’s presidential election, the record deforestation of the Amazon Rainforest, retail giant Amazon's objection to the Staten Island union vote, the worsening baby formula shortage, a lawsuit against Rutgers Law School, and a stomach illness possibly linked to Lucky Charms cereal.
SpaceX launched its first all commercial-crew mission to the International Space Station on Friday. Cheddar News speaks with Jim Cantrell, CEO and President of Phantom Space Corporation why this launch is a big leap for space tourism.
Nautilus Labs closed $34 million in funding from investors including the Microsoft Climate Innovation Fund. The company plans to use its funding to improve shipping industry efficiency with its software. Nautilus CEO Matt Heider joined Cheddar News to talk about how it tackles the carbon emissions in the global supply chain. "We've seen on 10-day voyages saving $60,000 worth of fuel just by managing speed with greater confidence around the future. The environmental impact of that is also huge," he said. "Saving that amount of fuel is a kind of taking over 1000 cars off the road this year."
For the first time microplastics have been found deep in the lungs of living humans. The trace materials potentially came from everyday items such as plastic bottles and bags. Dr. Jessica Shepherd, the chief medical officer at Verywell Health, joined Cheddar News to talk about the report's findings and to discuss the possible risks people might face. "The study’s most important part is we need to decrease our pollution, and we need to think about different ways to consume outside of plastic," she said.
An estimated five billion people lack access to affordable and safe surgical care around the world. For World Health Day, Cheddar News spoke with Kristie Magee Porcaro of Operation Smile, a nonprofit organization assisting with cleft lip and palate surgeries, about how they work to better it around the globe.
There has been notable disagreement in the medical community about a fourth COVID-19 vaccine dose. The FDA last week authorized a second booster dose for older and immunocompromised individuals, as some agency officials did not support the idea. The FDA made the decision without meeting with its advisory committee, as it had ahead of its recommendations on the previous COVID-19 vaccine doses.
The CDC followed in the footsteps of the FDA and authorized a fourth dose as well. Reports say the agency also did not discuss the move with its own advisory team of vaccine experts. Now, a growing number of doctors are speaking out against the decisions - leaving people confused about whether they should get another vaccine dose. Dr. Julie Morita, a member of the CDC's advisory committee to the director, and the executive vice president of the Robert Wood Johnson Foundation, joins Cheddar News' Closing Bell to discuss.
